Abrocitinib alleviates the symptoms of Netherton syndrome and is well tolerated
Our findings suggest that SPINK5 missense mutations may contribute to the pathogenesis of NS. Furthermore, Abrocitinib demonstrates promising therapeutic potential in the management of NS, warranting further investigation in larger clinical cohorts.
Authors
- Ying Tu (ORCID: https://orcid.org/0009-0008-0130-0239)
- Dongjie Sun (ORCID: https://orcid.org/0000-0002-0535-1534)
- Yue Qin
- Jun‐Ting Tang (ORCID: https://orcid.org/0000-0002-0530-4703)
- Weijia Zhao (ORCID: https://orcid.org/0009-0005-3461-3037)
Institutions
- Kunming Medical University (CN)
- First Affiliated Hospital of Kunming Medical University (CN)
Publication Details
- Journal
- Journal of Dermatological Treatment
- Published
- 2025-03-30
- DOI
- https://doi.org/10.1080/09546634.2024.2447883
- Citations
- 4
- Primary Topic
- Skin and Cellular Biology Research
- Type
- article
- Field-Weighted Citation Impact
- 4.61